RxDoctor Payments DataLook up a doctor →

Dominic Mazzocchi, MD

Internal Medicine · Point Pleasant Beach, NJNPI 1679546501

Payments from drug & device makers

$98,552in general payments, 2019–2025

Across 2,040 payments — averaging $48.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$36K
  • Amarin Pharma, Inc.$22K
  • Johnson & Johnson$12K
  • AstraZeneca$4K
  • Novo Nordisk$4K
  • GSK$3K
  • plus $16K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)504$36,299
Amarin Pharma, Inc.57$22,140
Johnson & Johnson183$12,485
AstraZeneca77$4,467
Novo Nordisk204$3,959
GSK137$2,921
Boehringer Ingelheim134$2,605
Takeda Pharmaceuticals U.S.A., Inc.65$2,182
Pfizer139$1,807
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC67$904
Lilly USA, LLC61$796
Amgen(2 entities)35$795
Biohaven Pharmaceutical Holding Company Ltd.32$660
E.r. Squibb & Sons, L.L.C.22$573
Biohaven Pharmaceuticals, Inc.43$480
Arbor Pharmaceuticals, Inc.36$384
Exact Sciences14$324
Paratek Pharmaceuticals, Inc.21$288
Bausch Health US, LLC19$275
Genentech USA, Inc.14$256
Sanofi-aventis U.S. LLC4$254
Teva Pharmaceuticals USA, Inc.8$227
Axsome Therapeutics, Inc.6$203
Bayer6$201
Lundbeck LLC6$198
Abbott4$176
Eisai Inc.13$168
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$165
Kowa Pharmaceuticals America, Inc.11$156
Madrigal Pharmaceuticals2$146
ARS Pharmaceuticals Operations, Inc.2$139
Indivior Inc.8$136
Idorsia Pharmaceuticals US Inc6$136
OPKO Pharmaceuticals, LLC1$125
Merck9$118
Esperion Therapeutics, Inc.1$112
Novartis7$109
Supernus Pharmaceuticals, Inc.5$89
Medtronic1$88
Nestle Healthcare Nutrition Inc.5$70
Currax Pharmaceuticals LLC4$56
Tris Pharma Inc4$56
Endo Pharmaceuticals Inc.4$55
Amneal Pharmaceuticals LLC3$53
Jazz Pharmaceuticals Inc.4$53
Avanir Pharmaceuticals, Inc.4$53
Almatica Pharma LLC3$48
Tolmar, Inc.3$47
Astellas Pharma US Inc2$38
Aytu Biopharma, Inc.3$38
Sumitomo Pharma America, Inc.2$32
Upsher-smith Laboratories LLC2$30
Antares Pharma, Inc.2$29
Azurity Pharmaceuticals, Inc.2$28
Biodelivery Sciences International, Inc.2$28
Sanofi Pasteur Inc.2$27
Boston Scientific1$26
Ironwood Pharmaceuticals, Inc2$23
Impel Pharmaceuticals Inc.1$21
Vivus LLC2$19

How this compares

$98,552 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024
$214,595
Medicare patients
578
Services billed
5,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Point Pleasant Beach

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →